Corticotropin-releasing hormone projections from the paraventricular nucleus of the hypothalamus to the nucleus of the solitary tract increase blood pressure.
Amphibian Proteins
/ pharmacology
Animals
Blood Pressure
Channelrhodopsins
/ antagonists & inhibitors
Corticotropin-Releasing Hormone
/ metabolism
Excitatory Amino Acid Antagonists
/ pharmacology
Female
Heart Rate
Kynurenic Acid
/ pharmacology
Male
Mice
Neurons
/ drug effects
Optogenetics
Paraventricular Hypothalamic Nucleus
/ cytology
Peptide Hormones
/ pharmacology
Solitary Nucleus
/ cytology
CRF
CRH
NTS
PVN
optogenetics
Journal
Journal of neurophysiology
ISSN: 1522-1598
Titre abrégé: J Neurophysiol
Pays: United States
ID NLM: 0375404
Informations de publication
Date de publication:
01 02 2019
01 02 2019
Historique:
pubmed:
20
12
2018
medline:
19
2
2020
entrez:
20
12
2018
Statut:
ppublish
Résumé
Activation of corticotropin-releasing hormone (CRH) type 2 receptors (CRHR2) in the nucleus of the solitary tract (NTS) contributes to the development of hypertension, but the source of CRH inputs to the NTS that increases blood pressure remains unknown. This study tested the hypothesis that activation of CRH-containing projections from the paraventricular nucleus of the hypothalamus (PVN) to the NTS increase blood pressure. We expressed channelrhodopsin 2 (ChR2), a light-sensitive ion channel, into CRH-containing neurons in the PVN. This was achieved by injecting Cre-inducible virus expressing ChR2 into the PVN of CRH-Cre mice. CRH-Cre mice are genetically modified mice expressing Cre recombinase only in neurons producing CRH. We found that optogenetic stimulation of CRH-containing somas in the PVN or CRH-containing fibers in the NTS originating from the PVN significantly increased blood pressure and heart rate. Microinjection of K-41498 (CRHR2 antagonist) into the NTS attenuated the pressor and tachycardiac responses induced by optogenetic stimulation of CRH-containing somas in the PVN. In vitro loose-patch recordings revealed that optogenetic stimulation of CRH-containing fibers in the NTS originating from the PVN significantly increased the discharge frequency of NTS neurons. This effect was attenuated by pretreatment of K-41498 and was abolished by pretreatment of kynurenic acid (nonselective glutamate receptor antagonist). These results suggest that activation of PVN-NTS CRH-containing projections increases blood pressure and heart rate. The cardiovascular responses may be mediated at least in part by the corelease of CRH and glutamate from NTS CRH-containing axons originating from the PVN. NEW & NOTEWORTHY Optogenetic stimulation of paraventricular nucleus of the hypothalamus (PVN) corticotropin-releasing hormone (CRH)-containing somas or nucleus of the solitary tract (NTS) CRH-containing fibers originating from the PVN increased blood pressure and heart rate. Corelease of CRH and glutamate from NTS CRH-containing axons originating from the PVN may contribute to the pressor and tachycardiac responses elicited by optogenetic stimulation of PVN CRH-containing somas.
Identifiants
pubmed: 30565964
doi: 10.1152/jn.00623.2018
pmc: PMC6397400
doi:
Substances chimiques
Amphibian Proteins
0
Channelrhodopsins
0
Excitatory Amino Acid Antagonists
0
Peptide Hormones
0
sauvagine
74434-59-6
Corticotropin-Releasing Hormone
9015-71-8
Kynurenic Acid
H030S2S85J
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
602-608Subventions
Organisme : NHLBI NIH HHS
ID : P01 HL088052
Pays : United States
Références
Am J Physiol Heart Circ Physiol. 2009 Jun;296(6):H2022-9
pubmed: 19395554
Hypertension. 2018 Oct;72(4):994-1001
pubmed: 30354709
Front Neurosci. 2013 Aug 30;7:156
pubmed: 24009552
J Neurosci. 2011 Apr 6;31(14):5205-12
pubmed: 21471355
Nat Commun. 2015 Apr 21;6:6770
pubmed: 25898242
J Neurosci. 2017 Mar 29;37(13):3478-3490
pubmed: 28219987
Brain Res. 1987 Dec 29;437(2):253-63
pubmed: 3325130
Clin Exp Pharmacol Physiol. 2005 May-Jun;32(5-6):447-9
pubmed: 15854156
Auton Neurosci. 2008 Nov 3;142(1-2):51-4
pubmed: 18804421
Physiol Behav. 2014 Sep;136:91-6
pubmed: 24704193
Annu Rev Physiol. 1994;56:93-116
pubmed: 7912060
J Endocrinol. 2017 Mar;232(3):R161-R172
pubmed: 28057867